– Funding Will Attain Below-Resourced Communities Most Impacted by the HIV Epidemic and COVID-19 Pandemic –
Gilead Sciences, Inc., (Nasdaq: GILD) as we speak introduced $24 million in grants to assist scale back well being disparities, enhance entry to high quality healthcare, advance medical training and assist native communities most impacted by the HIV epidemic and COVID-19 pandemic. The Zeroing In: Ending the HIV Epidemic program, will assist 116 organizations in 41 international locations. The funding recipients will concentrate on advancing no less than certainly one of three focus areas: Complete HIV Innovation, Digital Well being Innovation and Group Outreach and Schooling.
“Whereas the HIV neighborhood has made super progress towards ending the HIV epidemic, the COVID-19 pandemic created obstacles and amplified well being inequities in probably the most marginalized communities,” mentioned Alex Kalomparis, Senior Vice President, Public Affairs, Gilead Sciences. “We’re working with organizations that can attain under-resourced communities and assist them to search out revolutionary, efficient options. Zeroing In packages purpose to extend entry to HIV care and providers and construct on Gilead’s efforts to assist finish the epidemic for everybody, in every single place.”
“By way of Gilead Sciences’ Zeroing In program, a collective of 10 migrant-led frontline organizations throughout Europe have the chance to work collectively for the primary time to handle HIV information, testing and therapy obstacles amongst migrant communities,” mentioned Denis Onyango, Programmes Director, Africa Advocacy Basis.
“By way of this funding, we will enhance neighborhood consciousness of HIV and PrEP to marginalized communities throughout Mississippi, via skilled neighborhood well being employees. We plan to handle HIV stigma, and structural and institutional obstacles related to HIV care in Mississippi. It’s only via assist from organizations like Gilead that we’ll really be capable of finish the HIV epidemic,” mentioned Dr. Christopher Roby, Chief Operations Officer, Group Well being Middle Affiliation of Mississippi.
“This funding will empower very remoted households to handle their HIV at residence and to shortly entry medical care when further assist is required, with out creating undue monetary burdens on households which can be experiencing important hardship. It would additionally assist us fight the devastating stigma that exists round HIV all through Nepal. This can make it simpler to entry care, keep neighborhood ties, and preserve protected and wholesome,” mentioned Crystal Anderson, Grants and Donor Communications Supervisor, Nepal Youth Basis.
To construct on progress in native communities, Zeroing In organizations will prioritize populations most affected by the HIV epidemic. This consists of tasks from native organizations collaborating to finish the HIV epidemic of their respective cities, states, international locations or areas. Zeroing In organizations will concentrate on a number of of three areas:
- Complete HIV Innovation Packages: This consists of at-home testing efforts that assist shut the gaps in HIV testing and prevention, supportive service packages and complete HIV prevention packages inclusive of biomedical prevention choices.
- Digital Well being Improvements: Methods will deal with the well being literacy divide in accessing digital well being providers, assist digital entry in rural areas for higher outcomes for folks dwelling with HIV, or assist digital well being training for these with language obstacles, getting older populations, indigenous, migrant and stigmatized populations.
- Group Outreach and Schooling: Group-driven packages will present assets for HIV neighborhood outreach employees, deal with the dearth of culturally applicable service choices, break down obstacles between communities and repair suppliers, and scale back stigma and enhance training round HIV.
About Zeroing In
Zeroing In builds on earlier Gilead funding and grant packages, whereas supporting organizations to extend the general well being and wellness of communities most impacted by HIV and COVID-19. Gilead gives assist to organizations whose packages align with worldwide and country-specific Ending the HIV Epidemic objectives. This consists of local people programming and coalition-led proposals from organizations collaborating to finish the HIV epidemic of their respective metropolis, state, nation or area. Zeroing Inprogramming focuses on complete HIV innovation, digital well being innovation, and/or neighborhood outreach and training.
For extra info on Gilead’s Zeroing In: Ending the HIV Epidemic grant program, please go to https://www.gilead.com/purpose/giving/zeroing-in-ending-hiv-epidemic. A whole record of funded organizations could be discovered at https://www.gilead.com/-/media/files/pdfs/other/Zeroing-In-Grantee-List-for-Website.pdf.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical firm that has pursued and achieved breakthroughs in drugs for greater than three many years, with the objective of making a more healthy world for all folks. The corporate is dedicated to advancing revolutionary medicines to forestall and deal with life-threatening ailments, together with HIV, viral hepatitis and most cancers. Gilead operates in additional than 35 international locations worldwide, with headquarters in Foster Metropolis, California.
For greater than 30 years, Gilead has been a number one innovator within the discipline of HIV, driving advances in therapy, prevention and remedy analysis. Right this moment, hundreds of thousands of individuals dwelling with HIV globally obtain antiretroviral remedy supplied by Gilead or one of many firm’s manufacturing companions.
GILEAD and the GILEAD brand are logos of Gilead Sciences, Inc. All different logos are the property of their respective house owners.
For extra details about Gilead, please go to the corporate’s web site at www.gilead.com, observe Gilead on Twitter (@Gilead Sciences) or name Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.